This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.

The history of tropical medicine is as dramatic as the story of humankind. It has its own myths and legends, including tales of epidemics that destroyed whole civilizations. Today, with silent stealth, tropical diseases still claim more lives than all the current wars combined. Having had the privilege of working throughout Africa, Asia, and Latin America, as well as in the great medical centers of Europe and the United States, the author presents the details essential for understanding pathogenesis, clinical manifestations, therapy, and prevention of the major tropical diseases. The text, now in its eighth edition, has been used for half a century by medical students, practicing physicians, and public health workers around the world. This fascinating book should also be of interest to a broad, nonmedical readership interested in world affairs. All royalties from the sale of this book go to the training of humanitarian workers.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Networks in Tropical Medicine explores how European doctors and scientists worked together across borders to establish the new field of tropical medicine in the late nineteenth and early twentieth centuries. The book shows that this transnational collaboration in a context of European colonialism, scientific discovery, and internationalism shaped the character of the new medical specialty. Even in an era of intense competition among European states, practitioners of tropical medicine created a transnational scientific community through which they influenced each other and the health care that was introduced to the tropical world. One of the most important developments in the shaping of tropical medicine as a specialty was the major sleeping sickness epidemic that spread across sub-Saharan Africa at the turn of the century. The book describes how scientists and doctors collaborated across borders to control, contain, and find a treatment for the disease. It demonstrates that these medical specialists' shared notions of "Europeanness," rooted in common beliefs about scientific, technological, and racial superiority, led them to establish a colonial medical practice in Africa that sometimes oppressed the same people it was created to help.

The current value of global trade has reached a staggering annual figure of $6 trillion in merchandise crossing borders. Such prolific global trading has, at the same time, begun to raise fears of pandemics and concerns for global health. Yet, investment in public health infrastructure and disease control was never designed to cope with international trade of this volume and diversity. Indeed, most health systems lag far behind, especially in poor countries. This has created new vulnerabilities for global populations to the introduction and amplification of infection through trade. Public fears have been further heightened by frightening news reports of deadly diseases such as Mad Cow disease and E. Coli. Risky Trade: Infectious Disease in the Era of Global Trade provides a thorough examination of the actual risks posed by disease in the age of globalization. Drawing on the economics of international trade and epidemiology, the author explores the critical health issues arising from the enormous increase in global trade and travel. Issues covered include: ¢ The scale of the problem with particular reference to the Sakai outbreak of E. Coli; ¢ Risks from particular microbes - Enteric and viral infections; Highly infectious agents; Antimicrobial resistance; and, Stealth agents; ¢ Global outbreaks as a result of human travel and trade; ¢ Prevention, surveillance and control; ¢ The future health of global trading. In addition to highlighting the problems, the book also addresses some of the potential benefits the same globalization can bring to epidemic control through surveillance, diagnostics, treatment and investigation. The empirical approach ties together existing descriptions and case studies of epidemics building a comprehensive framework for examining new events and considering historical experience with infectious outbreaks. The volume will be a valuable guide to students, academics, practitioners, and policy makers in the areas of international trade, health economics, epidemiology, international/public health and disease control.

"The presence, or absence, of neglected tropical diseases (NTDs) can be seen as a proxy for poverty and for the success of interventions aimed at reducing poverty. Today, coverage of the public-health interventions recommended by the World Health Organization (WHO) against NTDs may be interpreted as a proxy for universal health coverage and shared prosperity - in short, a proxy for coverage against neglect. As the world's focus shifts from development to sustainable development, from poverty eradication to shared prosperity, and from disease-specific goals to universal health coverage, control of NTDs will assume an important role towards the target of achieving universal health coverage, including individual financial risk protection. Success in overcoming NTDs is a "litmus test" for universal health coverage against NTDs in endemic countries. The first WHO report on NTDs (2010) set the scene by presenting the evidence for how these interventions had produced results. The second report (2013) assessed the progress made in deploying them and detailed the obstacles to their implementation. This third report analyses for the first time the investments needed to achieve the scale up of implementation required to achieve the targets of the WHO Roadmap on NTDs and universal coverage against NTDs. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES presents an investment strategy for NTDs and analyses the specific investment case for prevention, control, elimination and eradication of 12 of the 17 NTDs. Such an analysis is justified following the adoption by the Sixty-sixth World Health Assembly in 2013 of resolution WHA6612 on neglected tropical diseases, which called for sufficient and predictable funding to achieve the Roadmap's targets and sustain control efforts. The report cautions, however, that it is wise investment and not investment alone that will yield success. The report registers progress and challenges and signals those that lie ahead. Climate change is expected to increase the spread of several vector-borne NTDs, notably dengue, transmission of which is directly influenced by temperature, rainfall, relative humidity and climate variability primarily through their effects on the vector. Investments in vector-borne diseases will avoid the potentially catastrophic expenditures associated with their control. The presence of NTDs will thereby signal an early warning system for climate-sensitive diseases. The ultimate goal is to deliver enhanced and equitable interventions to the most marginalized populations in the context of a changing public-health and investment landscape to ensure that all peoples affected by NTDs have an opportunity to lead healthier and wealthier lives."--Publisher's description.

Tropical Diseases outlines the diagnosis, prevention, and treatment of diseases encountered in developing regions—-areas where the unexpected can occur and where Western medical capabilities are often unavailable. Taking a pragmatic approach, it is an invaluable reference and resource for medical professionals and students travelling abroad or working in unfamiliar terrain. Diseases profiled here include a brief historical background, main signs and symptoms, and practical methods of individual prevention and treatment. Additional features include: - Over 60 maps depicting the geographic origins and modern distribution of tropical diseases - A classification scheme for parasitic diseases according to the location of the final parasitic stage in the human body - Clinical case studies For the new or experienced health care provider, Tropical Diseases is a handy, practical guide to treating and avoiding disease in any environment. Yann Meunier is the CEO of HealthConnect International Inc, a healthcare consulting company based in Silicon Valley, CA, and Advisor in the Medscholars Research Fellowships Program at Stanford University School of Medicine. He is honorary member of the Brazilian Academy of Medicine, associate member of the Academy of Medicine, Singapore, member of the International Academy of Fellows and Associates, Royal College of Physicians and Surgeons of Canada and fellow of the Australasian College of Tropical Medicine. He received his Tropical Medicine specialty degree from the university Paris VI and was consultant in Tropical Medicine at the Pitié-Salpêtrière in Paris. He has practiced medicine for many years in Africa, Asia, Oceania and South America.